88 related articles for article (PubMed ID: 1427442)
1. In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia.
Catani L; Gugliotta L; Zauli G; Bagnara GP; Antonelli G; Belmonte MM; Vianelli N; Bonsi L; Brunelli MA; Tura S
Haematologica; 1992; 77(4):318-21. PubMed ID: 1427442
[TBL] [Abstract][Full Text] [Related]
2. [Essential thrombocythemia: therapy with alpha interferons].
Gugliotta L; Catani L; Vianelli N; Mattioli Belmonte M; Cascione ML; Bendani M; Fanin R; Michieli MG; Baccarani M; Tura S
Haematologica; 1991 Jun; 76 Suppl 3():374-7. PubMed ID: 1752536
[No Abstract] [Full Text] [Related]
3. In vivo and in vitro inhibitory effect of alpha-interferon on megakaryocyte colony growth in essential thrombocythaemia.
Gugliotta L; Bagnara GP; Catani L; Gaggioli L; Guarini A; Zauli G; Belmonte MM; Lauria F; Macchi S; Tura S
Br J Haematol; 1989 Feb; 71(2):177-81. PubMed ID: 2923804
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha.
Russo D; Candoni A; Zuffa E; Minisini R; Silvestri F; Fanin R; Zaja F; Martinelli G; Tura S; Botta G; Baccarani M
Br J Haematol; 1996 Aug; 94(2):300-5. PubMed ID: 8759890
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha in the treatment of essential thrombocythemia.
Lengfelder E; Griesshammer M; Hehlmann R
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():135-42. PubMed ID: 8951784
[TBL] [Abstract][Full Text] [Related]
6. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
[TBL] [Abstract][Full Text] [Related]
7. Therapy-induced antibodies against the antiviral and antiproliferative effects of interferons in patients with chronic hepatitis C virus infection.
Bálint E; Bakay M; Onody K; Farkas F; Horváth G; Tolvaj G; Dávid K; Horányi M; Béládi I
Acta Microbiol Immunol Hung; 2004; 51(3):359-69. PubMed ID: 15571075
[TBL] [Abstract][Full Text] [Related]
8. [Effect of in vitro interferon on bone marrow megakaryocyte in patients with idiopathic thrombocytopenic purpura].
Xue M; Deng C; Meng W; Wei J
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Sep; 30(3):306-9. PubMed ID: 12212292
[TBL] [Abstract][Full Text] [Related]
9. Treatment of essential thrombocythaemia by alpha 2a interferon.
Bellucci S; Harousseau JL; Brice P; Tobelem G
Lancet; 1988 Oct; 2(8617):960-1. PubMed ID: 2902403
[No Abstract] [Full Text] [Related]
10. Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes.
Brand CM; Leadbeater L; Bellati G; Marotta F; Ideo G
J Interferon Res; 1993 Apr; 13(2):121-5. PubMed ID: 7685368
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to interferon-alpha 2 in patients treated with interferon-alpha 2 for hairy cell leukemia.
Bekisz JB; zur Nedden DL; Enterline JC; Zoon KC
J Interferon Res; 1989 Sep; 9 Suppl 1():S1-7. PubMed ID: 2809275
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture.
Tiefenthaler M; Geisen F; Schirmer M; Konwalinka G
J Interferon Cytokine Res; 1997 Jun; 17(6):327-9. PubMed ID: 9197999
[TBL] [Abstract][Full Text] [Related]
14. Human leucocyte interferon-alpha therapy can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-alfa 2a.
Merup M; Törnebohm-Roche E; Engman K; Paul C
Eur J Cancer; 1994; 30A(11):1729-30. PubMed ID: 7833154
[No Abstract] [Full Text] [Related]
15. Interferon-gamma enhances megakaryocyte colony-stimulating activity in murine bone marrow cells.
Tsuji-Takayama K; Tahata H; Harashima A; Nishida Y; Izumi N; Fukuda S; Ohta T; Kurimoto M
J Interferon Cytokine Res; 1996 Sep; 16(9):701-8. PubMed ID: 8887054
[TBL] [Abstract][Full Text] [Related]
16. Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-alpha and IFN-beta antibodies.
Prümmer O; Streichan U; Heimpel H; Porzsolt F
J Immunol Methods; 1994 May; 171(1):45-53. PubMed ID: 8176238
[TBL] [Abstract][Full Text] [Related]
17. [alpha-Interferon in the treatment of essential thrombocythemia].
Hashizume M; Iki S; Yagisawa M; Ohbayashi Y; Sato H; Urabe A
Rinsho Ketsueki; 1992 Feb; 33(2):232-7. PubMed ID: 1635175
[TBL] [Abstract][Full Text] [Related]
18. Alpha interferon raises serum beta-2-microglobulin in patients treated for thrombocythaemia.
Remes K; Tienhaara A; Pelliniemi TT
Br J Haematol; 1993 Jun; 84(2):353-5. PubMed ID: 8398845
[TBL] [Abstract][Full Text] [Related]
19. Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment.
Rönnblom LE; Janson ET; Perers A; Oberg KE; Alm GV
Clin Exp Immunol; 1992 Sep; 89(3):330-5. PubMed ID: 1516252
[TBL] [Abstract][Full Text] [Related]
20. Maintenance therapy in the myeloproliferative disorders: the current options.
Giles FJ
Br J Haematol; 1991 Oct; 79 Suppl 1():92-5. PubMed ID: 1931719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
